Does DARBEPOETIN ALFA Cause Therapy partial responder? 20 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 20 reports of Therapy partial responder have been filed in association with DARBEPOETIN ALFA (ARANESP). This represents 0.1% of all adverse event reports for DARBEPOETIN ALFA.
20
Reports of Therapy partial responder with DARBEPOETIN ALFA
0.1%
of all DARBEPOETIN ALFA reports
6
Deaths
4
Hospitalizations
How Dangerous Is Therapy partial responder From DARBEPOETIN ALFA?
Of the 20 reports, 6 (30.0%) resulted in death, 4 (20.0%) required hospitalization, and 2 (10.0%) were considered life-threatening.
Is Therapy partial responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DARBEPOETIN ALFA. However, 20 reports have been filed with the FAERS database.
What Other Side Effects Does DARBEPOETIN ALFA Cause?
Death (12,264)
Hospitalisation (5,682)
Product storage error (1,619)
Off label use (1,586)
Circumstance or information capable of leading to medication error (1,050)
Haemodialysis (907)
Pneumonia (733)
Fall (726)
Anaemia (562)
Dialysis (555)
What Other Drugs Cause Therapy partial responder?
CYCLOPHOSPHAMIDE (1,397)
RITUXIMAB (1,219)
DEXAMETHASONE (1,199)
PREDNISONE (1,176)
PEMBROLIZUMAB (1,125)
CARBOPLATIN (1,096)
DOXORUBICIN (834)
METHOTREXATE (775)
VINCRISTINE (707)
ETOPOSIDE (670)
Which DARBEPOETIN ALFA Alternatives Have Lower Therapy partial responder Risk?
DARBEPOETIN ALFA vs DARIDOREXANT
DARBEPOETIN ALFA vs DARIFENACIN HYDROBROMIDE
DARBEPOETIN ALFA vs DAROLUTAMIDE
DARBEPOETIN ALFA vs DARUNAVIR
DARBEPOETIN ALFA vs DARUNAVIR ETHANOLATE